November 21, 2024
Guo Mingrui, Ruisong Su, Jeff Chor, Zheyan Zhang, Mandy Tan, Xing Qi Teo, Haosheng Feng, Kuan Jin Lee, Aaron Hua, Longyun Zhang, Jie Cai, Guanping Mao, Jessie (Jingjing) Wang, Keefe Chng, Weiping Han, Colin Guo
Accurate monitoring of orthotopic tumors in oncological research is critical. Common imaging methods including bioluminescence imaging (BLI), ultrasound imaging (US,) and computed tomography (CT) each have advantages and limitations.
MRI has been introduced as a modality to overcome these limitations. This study compares BLI and MRI in tracking tumor progression, focusing on the human glioblastoma multiforme (GBM) orthotopic xenograft mouse model.
MRI-based tumor tracking opens the possibility to use more clinically relevant patient derived xenograft (PDX) models of GBM in an orthotopic manner, improving the clinical transability to evaluate new GBM treatment modalities.
Your privacy is important to us.
We'll never share your information.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy
2024-04-11
2024-03-28
landing_page
AACR 2024